I couldn't find the forecast, but the $13.7mm you noted doesn't go far when you're burning $22MM plus annually, diluting the stock, and $220,000,000 deficit. The whole thing is so convoluted it's impossible to understand their non-gaap numbers. Those numbers are useless. Here's what matters:
Very confusing. I just don't see how they get to 25' rev est 13.7 mil. I mean these are the numbers: get this-->SALES 2025 $13.77M +4,521.83%<-------- This POET if that is true.. should be north of $25. also between 2025 and 2026 we swing from loss to profit this is always the best time to be in a name we go from -26c to +.33<---- There is no easing into earn!!!! This represents a PE of 11. More reliable CARR Carrier Global Corporation had an outsized vol day on the $ story selling division. $62.94-0.30(-0.47%)12:22 PM 07/08/24 NYSE |$USD |Realtime
I'd keep an eye out just in case. how negative should I be with the HF.-- This is the big question for me right now. Phone consult this week they want to sell. tax implications. etc.
comfy set up flagging since June 6 GBA Upgrade-->TWST Twist Bioscience Corporation $49.32 0.85(+1.75%)12:51 PM 07/08/24 NASDAQ |$USD |Realtime
They're coming after you Stoney... Danbury,CT today Arthur J. Gallagher & Co. Acquires Cleary Benefits Group Inc. ROLLING MEADOWS, Ill., July 8, 2024 /PRNewswire/ -- Arthur J. Gallagher & Co. today announced the acquisition of Danbury, Connecticut-based Cleary Benefits Group Inc. Terms of the transaction were not disclosed.<----